MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

hyperandrogenism

  • Home
  • hyperandrogenism
Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications
Posted inClinical Updates Diabetes & Endocrinology news

Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications

Posted by By MedXY 12/27/2025
Recent evidence reveals that one in four premenopausal women with Type 1 diabetes (T1D) suffers from undiagnosed androgen excess disorders, primarily the classic PCOS phenotype, necessitating routine screening and a recalibration of reproductive healthcare in diabetic management.
Read More
One in Four Premenopausal Women with Type 1 Diabetes Faces Undiagnosed Androgen Excess Disorders
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health

One in Four Premenopausal Women with Type 1 Diabetes Faces Undiagnosed Androgen Excess Disorders

Posted by By MedXY 12/27/2025
A cross-sectional study reveals that 26% of women with Type 1 Diabetes suffer from undiagnosed androgen excess, primarily PCOS. The findings emphasize the role of iatrogenic hyperinsulinism and advocate for routine screening, especially for those with premenarcheal diabetes onset.
Read More
Understanding Idiopathic Hirsutism: A Misnomer in Medical Science?
Posted innews OB/GYN & Women's Health Specialties

Understanding Idiopathic Hirsutism: A Misnomer in Medical Science?

Posted by By MedXY 07/28/2025
Idiopathic hirsutism, characterized by excessive hair growth, may not be truly idiopathic. Research suggests underlying androgen mechanisms could redefine its classification.
Read More
  • Intranasal vs. Subcutaneous Ketamine for Acute Traumatic Pain in the ED: Comparable Efficacy and Safety
  • Evaluating Sphenopalatine Ganglion Block Dosage for Headache Relief in the Emergency Department
  • Dose-Dependent Effects of Produce Prescriptions: Insights from a Randomized Community Trial and Broader Evidence
  • Impact of Medicaid Prescription Cap Removal on ART Adherence and Health Care Utilization Among People with HIV
  • Physicians’ Perspectives on Managing Asymptomatic Elevated Blood Pressure in Hospitalized Patients: Insights from a Nationwide Survey
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top